Impact of age on outcomes of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in elderly patients with acute myeloid leukemia-Reference-Cited by-同舟云学术

Impact of age on outcomes of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in elderly patients with acute myeloid leukemia

Published:2016-01-11 Issue:3 Volume:91 Page:302-307
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Aoki Jun¹,Kanamori Heiwa¹,Tanaka Masatsugu¹,Yamasaki Satoshi²,Fukuda Takahiro³,Ogawa Hiroyasu⁴,Iwato Koji⁵,Ohashi Kazuteru⁶,Okumura Hirokazu⁷,Onizuka Makoto⁸,Maesako Yoshitomo⁹,Teshima Takanori¹⁰,Kobayashi Naoki¹¹,Morishima Yasuo¹²,Hirokawa Makoto¹³,Atsuta Yoshiko¹⁴¹⁵,Yano Shingo¹⁶,Takami Akiyoshi¹⁷

Affiliation:

1. Department of Hematology; Kanagawa Cancer Center; Yokohama Japan

2. Department of Hematology and Clinical Research Institute; National Hospital Organization Kyushu Medical Center; Fukuoka Japan

3. Division of Hematopoietic Stem Cell Transplantation; National Cancer Center Hospital; Tokyo Japan

4. Division of Hematology; Department of Internal Medicine; Hyogo College of Medicine; Hyogo Japan

5. Department of Hematology; Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital; Hiroshima Japan

6. Department of Hematology; Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital; Tokyo Japan

7. Department of Internal Medicine; Toyama Prefectural Central Hospital; Toyama Japan

8. Department of Hematology/Oncology; Tokai University School of Medicine; Isehara Japan

9. Department of Hematology; Tenri Hospital; Tenri Japan

10. Department of Hematology; Hokkaido University Hospital; Sapporo Japan

11. Department of Hematology; Sapporo Hokuyu Hospital; Sapporo Japan

12. Division of Epidemiology and Prevention; Aichi Cancer Center Research Institute; Aichi Japan

13. Department of General Internal Medicine and Clinical Laboratory Medicine; Akita University Graduate School of Medicine; Akita Japan

14. Japanese Data Center for Hematopoietic Cell Transplantation; Nagoya Japan

15. Department of Healthcare Administration; Nagoya University Graduate School of Medicine; Nagoya Japan

16. Division of Clinical Oncology and Hematology; Department of Internal Medicine; Jikei University School of Medicine; Tokyo Japan

17. Division of Hematology; Department of Internal Medicine; Aichi Medical University; Aichi Japan

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.24270/fullpdf

Reference23 articles.

1. Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet;Dohner;Blood,2010

2. Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: Myths, controversies, and unknowns;Gupta;Blood,2011

3. Allogeneic myeloablative transplantation for patients aged 50 years and over;Yanada;Bone Marrow Transplant,2004

4. How I treat the older patient with acute myeloid leukemia;Ossenkoppele;Blood,2015

5. Reduced-intensity conditioning for acute myeloid leukemia: Is this strategy correct;Lazarus;Leukemia,2006

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LILRB4 in acute myeloid leukemia: From prognostic biomarker to immunotherapeutic target;Chinese Medical Journal;2024-07-08

2. Impact of chronic graft- versus -host disease on non-relapse mortality and survival;Leukemia & Lymphoma;2024-06-12

3. Development and Validation of a Concise Objectifiable Risk Evaluation Score for Non-Relapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation;Cancers;2024-01-25

4. Microtransplantation, an option to explore in hematological malignancies: A review article;The Egyptian Journal of Haematology;2023-10

5. Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets;Expert Opinion on Investigational Drugs;2023-02-01